Cathie Wood Regeneron Pharmaceuticals, Inc. Transaction History
Ark Investment Management LLC
- $9.28 Billion
- Q1 2025
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 13,694 shares of REGN stock, worth $8.42 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
13,694
Previous 13,192
3.81%
Holding current value
$8.42 Million
Previous $9.4 Million
7.58%
% of portfolio
0.09%
Previous 0.08%
Shares
32 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
85.7MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.78 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.19 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.48 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.94 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.45 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $65.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...